These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Regression of post-transplant Kaposi's sarcoma using sirolimus. Kolhe N; Mamode N; Van der Walt J; Pattison J Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440 [TBL] [Abstract][Full Text] [Related]
45. Skin cancer after renal transplantation: Results of a multicenter study in Iran. Einollahi B; Nemati E; Lessan-Pezeshki M; Simforoosh N; Nourbala MH; Rostami Z; Nafar M; Pourfarziani V; Beiraghdar F; Mahdavi-Mazdeh M; Ahmadpour P; Makhdoomi K; Ghafari A; Ardalan MR; Taebi Khosroshahi H; Oliaei F; Shahidi S; Makhlogh A; Azmandian J; Samimagham HR; Shabazian H Ann Transplant; 2010; 15(3):44-50. PubMed ID: 20877266 [TBL] [Abstract][Full Text] [Related]
46. Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy. Zamanian A; Farshchian M J Drugs Dermatol; 2007 Jul; 6(7):703-6. PubMed ID: 17763593 [TBL] [Abstract][Full Text] [Related]
47. Posttransplant malignancies and their relationship with human leukocyte antigens in kidney allograft recipients. Azmandian J; Lessan-Pezeshki M; Alipour Abedi B; Mahdavi-Mazdeh M; Nafar M; Farhangi S Iran J Kidney Dis; 2007 Oct; 1(2):98-101. PubMed ID: 19363276 [TBL] [Abstract][Full Text] [Related]
48. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology. Valantine H J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777 [TBL] [Abstract][Full Text] [Related]
49. Iatrogenic Kaposi's sarcoma: HHV8 positivity persists but the tumors regress almost completely without immunosuppressive therapy. Nagy S; Gyulai R; Kemeny L; Szenohradszky P; Dobozy A Transplantation; 2000 May; 69(10):2230-1. PubMed ID: 10852635 [No Abstract] [Full Text] [Related]
50. Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation. Eisen HJ; Hobbs RE; Davis SF; Laufer G; Mancini DM; Renlund DG; Valantine H; Ventura H; Vachiery JL; Bourge RC; Canver CC; Carrier M; Costanzo MR; Copeland J; Dureau G; Frazier OH; Dorent R; Hauptman PJ; Kells C; Master R; Michaud JL; Paradis I; Smith A; Vanhaecke J; Mueller EA Transplantation; 1999 Sep; 68(5):663-71. PubMed ID: 10507486 [TBL] [Abstract][Full Text] [Related]
54. Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab. Budde K; Bosmans JL; Sennesael J; Zeier M; Pisarski P; Schütz M; Fischer W; Neumayer HH; Glander P Clin Nephrol; 2007 Mar; 67(3):164-75. PubMed ID: 17390741 [TBL] [Abstract][Full Text] [Related]
56. Lymphoma-the most common neoplasia in renal transplant recipients. Ghods AJ; Ossareh S Transplant Proc; 2000 May; 32(3):585-6. PubMed ID: 10812123 [No Abstract] [Full Text] [Related]
57. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma. Campistol JM; Gutierrez-Dalmau A; Torregrosa JV Transplantation; 2004 Mar; 77(5):760-2. PubMed ID: 15021843 [TBL] [Abstract][Full Text] [Related]
58. Modelling time-dependent interaction in a time-varying covariate and its application to rejection episodes and kidney transplant failure. Heisey DM; Foong AP Biometrics; 1998 Jun; 54(2):712-9. PubMed ID: 9629651 [TBL] [Abstract][Full Text] [Related]
59. [To further improve transplantation results]. Chirurg; 2002 Dec; 73(12):2 p following M392. PubMed ID: 12599314 [No Abstract] [Full Text] [Related]
60. Kaposi's sarcoma occurring in a cardiac transplant patient on tacrolimus. Chua R; Macdonald P Heart Lung Circ; 2006 Oct; 15(5):340-1. PubMed ID: 16781193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]